BiomX (PHGE) Surges as BX211 Cuts Diabetic Wounds by 40%
BiomX Inc. (NASDAQ:PHGE) is a clinical-stage biotechnology company pioneering the development of bacteriophage-based therapies designed to target harmful…
Browsing Tag